Entero Healthcare to Sell Entire Stake in Suprabhat Pharmaceutical and Acquire 60% in Ace Cardiopathy Solutions

Entero Healthcare Solutions Ltd announced that its Board of Directors has approved the sale of its entire stake in Suprabhat Pharmaceutical Private Limited, a wholly-owned subsidiary, and the acquisition of 60% stake in Ace Cardiopathy Solutions Private Limited. The sale of Suprabhat is expected to be completed during the Financial Year 2025-26, while the acquisition of Ace Cardiopathy is expected to be completed by January 31, 2026. The acquisition will be through cash consideration, with the cost ranging between INR 59.30 Crore to INR 77.10 Crore, subject to adjustments for net debt, normalized working capital, and achievement of certain conditions.